Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients.

The authors from Taiwan state that they used “Ferrum Hausmann, a ferric polymaltose complex.” Under the same name (Ferrum Hausmann), iron saccharate (identical to iron sucrose) has been licensed in several European countries. The confusion concerning various iron sugar compounds gets even greater when one considers that “ferric polymaltose complex” was reported as being used […]

A randomized trial of iron deficiency testing strategies in hemodialysis patients.

It is well known that Ferritin and Transf.sat are parameters that are influenced by various factors such as inflammation, iron overload, varying serum iron levels, etc. Therefore, better parameters are needed and hypochromic red cells are one of the most promising concerning correct titration of parenteral iron. Reticulocyte Hb content (CHr) decreases singnificantly if functional […]

Considerations for optimal iron use for anemia due to chronic kidney disease.

It is certainly of great value to have an overview about different iron regimens in combination with rHuEPO. However, at least in Europe, there is common agreement that parenteral iron and, if used as such, iron sucrose is the gold standard in combination with rHuEPO as regards safety and effectiveness. Monitoring of efficiency is based […]

Fetal parvovirus B19 infection.

The article gives a good overview about incidence, pathogenesis, clinical symptoms, clinical course, diagnostics, therapy and prognosis of fetal parvovirus B19 infection by analysis of literature. The prognosis is mainly determined by the anemia. Data suggest a benefit of transfusion therapy. – V. Kretschmer.

Consent Management Platform by Real Cookie Banner